In this contribution we present the main features of the plasma coagulation controller (PCC) device, a cold atmospheric pressure plasma source based on the dielectric barrier discharge (DBD) scheme, specifically designed for accelerating blood coagulation. The device is controlled by a microcontroller and can be used to explore different operational parameters in terms of discharge repetition rate (1-20 kHz) and applied voltage (2-8 kV). Helium is used as a working gas. Effective current measured on a metallic target is of the order of 1 mA and, thus, is suitable for application on the human body. Emission spectroscopy analysis is performed: the presence in the plasma of reactive oxygen species (ROS) and reactive nitrogen species (RNS) is highlighted in the different operational regimes. We present the results ofmultiple tests using the device in different biological processes, including reactive species production, bacterial removal, and in vitro blood coagulation. Interestingly, tests on blood samples exposed to the helium plasma at different times show a significant reduction ofthe coagulation compared to control samples.

Plasma Coagulation Controller: A Low- Power Atmospheric Plasma Source for Accelerated Blood Coagulation

De Masi G;Martines E;Zuin M;
2018

Abstract

In this contribution we present the main features of the plasma coagulation controller (PCC) device, a cold atmospheric pressure plasma source based on the dielectric barrier discharge (DBD) scheme, specifically designed for accelerating blood coagulation. The device is controlled by a microcontroller and can be used to explore different operational parameters in terms of discharge repetition rate (1-20 kHz) and applied voltage (2-8 kV). Helium is used as a working gas. Effective current measured on a metallic target is of the order of 1 mA and, thus, is suitable for application on the human body. Emission spectroscopy analysis is performed: the presence in the plasma of reactive oxygen species (ROS) and reactive nitrogen species (RNS) is highlighted in the different operational regimes. We present the results ofmultiple tests using the device in different biological processes, including reactive species production, bacterial removal, and in vitro blood coagulation. Interestingly, tests on blood samples exposed to the helium plasma at different times show a significant reduction ofthe coagulation compared to control samples.
2018
Istituto gas ionizzati - IGI - Sede Padova
Inglese
8
3
245
254
10
http://www.dl.begellhouse.com/journals/5a5b4a3d419387fb,56c6606e6c828bb0,1f817c1d340d7784.html
plasma medicine
atmospheric pressure plasma applications
dielectric barrier discharge
biomedical applications
ISSN Print: 1947-5764 / ISSN Online: 1947-5772 / This work has been conducted as a part of the three-year research project named "A novel plasma medicine tool for accelerated heamostasis," which has received funding from the "Fondazione con il Sud" within the call "Brains2South."
2
info:eu-repo/semantics/article
262
De Masi G.; Gareri C.; Cordaro L.; Fassina A.; Brun P.; Zaniol B.; Cavazzana R.; Martines E.; Zuin M.; marinaro G.; De Rosa S.; Indolfi C.;
01 Contributo su Rivista::01.01 Articolo in rivista
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/358975
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 12
  • ???jsp.display-item.citation.isi??? ND
social impact